Maximus, Inc. (NYSE:MMS - Get Free Report) announced a quarterly dividend on Monday, October 5th. Shareholders of record on Friday, November 13th will be given a dividend of $0.33 per share by the health services provider on Monday, November 30th. This represents a $1.32 annualized dividend and a yield of 2.4%. The ex-dividend date of this dividend is Friday, November 13th.
Maximus has increased its dividend by an average of 0.0%annually over the last three years and has increased its dividend every year for the last 2 years. Maximus has a payout ratio of 19.8% meaning its dividend is sufficiently covered by earnings. Equities analysts expect Maximus to earn $8.36 per share next year, which means the company should continue to be able to cover its $1.32 annual dividend with an expected future payout ratio of 15.8%.
Maximus Price Performance
Shares of MMS stock traded up $1.76 during trading hours on Monday, reaching $54.41. The company's stock had a trading volume of 731,514 shares, compared to its average volume of 726,991. The firm's 50 day simple moving average is $57.18 and its 200-day simple moving average is $60.09. The company has a market capitalization of $2.85 billion, a price-to-earnings ratio of 8.04 and a beta of 0.59. Maximus has a fifty-two week low of $51.04 and a fifty-two week high of $100.00. The company has a quick ratio of 2.42, a current ratio of 2.42 and a debt-to-equity ratio of 0.90.
Maximus (NYSE:MMS - Get Free Report) last posted its quarterly earnings results on Thursday, August 6th. The health services provider reported $2.22 EPS for the quarter, topping analysts' consensus estimates of $2.21 by $0.01. Maximus had a return on equity of 24.91% and a net margin of 7.07%.The company had revenue of $1.28 billion during the quarter, compared to analysts' expectations of $1.33 billion. During the same quarter in the previous year, the firm earned $2.16 EPS. Maximus's revenue was down 5.1% on a year-over-year basis. Maximus has set its FY 2026 guidance at 7.900-8.200 EPS. Sell-side analysts forecast that Maximus will post 8.03 earnings per share for the current year.
Insider Activity
In other news, insider Michelle Link sold 3,208 shares of Maximus stock in a transaction on Thursday, October 1st. The shares were sold at an average price of $54.23, for a total transaction of $173,969.84. Following the transaction, the insider owned 13,881 shares in the company, valued at approximately $752,766.63. The trade was a 18.77% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 1.80% of the company's stock.
Institutional Investors Weigh In On Maximus
Several institutional investors and hedge funds have recently made changes to their positions in the stock. Integrated Wealth Concepts LLC acquired a new position in shares of Maximus in the second quarter worth approximately $34,000. Global Retirement Partners LLC acquired a new stake in Maximus during the 2nd quarter valued at approximately $40,000. Archer Investment Corp bought a new position in Maximus during the 2nd quarter worth approximately $43,000. Blue Trust Inc. lifted its position in shares of Maximus by 14.6% in the 1st quarter. Blue Trust Inc. now owns 1,321 shares of the health services provider's stock worth $85,000 after purchasing an additional 168 shares during the period. Finally, Palladiem LLC acquired a new position in shares of Maximus in the 4th quarter worth approximately $85,000. Institutional investors and hedge funds own 97.21% of the company's stock.
About Maximus
(
Get Free Report)
Maximus, Inc NYSE: MMS is a provider of government services and technology-enabled solutions. The company partners with federal, state, provincial and local governments to administer public programs, improve service delivery and support interactions between governments and the people they serve.
Its business activities include health and human services administration, employment and workforce services, child support and eligibility services, customer contact centers, program management, consulting and digital transformation.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.